Cambodia vs United States of America: Confirmed cases of RR-/MDR-TB
Cambodia
148
in 2024
United States of America
133
in 2023
Cambodia rank
60th
United States of America rank
63rd
Confirmed cases of RR-/MDR-TB over time
- Cambodia
- United States of America
How they compare
Cambodia currently reports 148 against 133 in United States of America, a difference of 15.
That makes Cambodia's figure about 1.1 times United States of America's.
The two have swapped places 6 times across 16 shared years of data; in 2007 it was United States of America ahead.
Cambodia ranks 60th and United States of America ranks 63rd of 195 countries.
United States of America has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Cambodia | United States of America | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 16.33 | 169 | 152.67 | United States of America |
| 2010s | 105.7 | 118 | 12.3 | United States of America |
| 2020s | 109.33 | 116.67 | 7.33 | United States of America |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher confirmed cases of rr-/mdr-tb, Cambodia or United States of America?
- Cambodia, at 148 against 133 in United States of America as of 2024.
- What is the difference in confirmed cases of rr-/mdr-tb between Cambodia and United States of America?
- 15, with Cambodia ahead.
- How many years of comparable data are there for Cambodia and United States of America?
- 16 years are reported by both, from 2007 to 2023.
- How do Cambodia and United States of America rank globally for confirmed cases of rr-/mdr-tb?
- Cambodia ranks 60th and United States of America ranks 63rd of 195 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Confirmed cases of RR-/MDR-TB. Statizoid refreshes it automatically from the source and publishes the full history for both places.